Evaluation of Dysfunction of the Basal Ganglia Before a Parkinsonian Walking in the Elderly: Risk of Falling and Confusional State

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-03-20

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The strong relationship between falling and severity of cognitive impairment in the elderly is well established. The association premorbid gait and executive disorders suggests that they are under tension by the same mechanisms. The gait fortiori neurological are fall risk factors. Dysfunctions underlying disorders as Parkinson called march executive disorders are subcortical origin involving so the basal ganglia. This study is indeed based on the assumption that the dysfunction of the basal ganglia as observed in parkinsonian syndromes resulting in disorders of posture and walking, by dysexecutive syndrome, anxiety and the contrast vision disorders. These gait exposed to falls and dysexecutive these disorders with cognitive impairment and greater susceptibility to confusional states. The executive disorders, gait disorders, anxiety, disturbances of vision and especially saccadic eye movements, impaired vision contrasts are well established in the degenerative parkinsonian syndromes. This study proposes a new approach to assessing gait disorders to define a high risk of falling in the presence of parkinsonian walking in the elderly over 75 years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neuropsychological Assessment of Cognitive Decline in Patients With a Definite Parkinson's Disease

NCT01113242

Parkinson Disease Dementia

COMPLETED

Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient

NCT02859805

Parkinson Disease

COMPLETED

Evaluation of Behaviour in Parkinson's Disease. Normal Values in Healthy Subjects

NCT02820428

Behaviour

COMPLETED NA

Frailty and Cognitive Function in Parkinson's Disease.

NCT05388526

Parkinson Disease

COMPLETED

Gait Control in Parkinson Disease

NCT05908279

Parkinson Disease

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

the Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Falls is <or = 1 year

Patients whose number of falls is \<or = 1 year

tests

Intervention Type BEHAVIORAL

falls is> 1 year

Patients whose numbers falls is\> 1 year

tests

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tests

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 75 years,
* man or woman,
* Diagnostic Criteria for Parkinson walking: at least 3 of the following symptoms:
* Loss of swinging arms,
* Decrease in stride walking slowly,
* feet as glued to the ground,
* Trample,
* piece U-turn,
* kyphotic Attitude,
* Tolerance screw physiotherapy screws

Exclusion Criteria

* Unrecovered delirium,
* Unable to walk for a distance of 6 meters in length without technical assistance,
* Traumatic fall phase of rehabilitation,
* Acute pathology,
* Unstabilized psychiatric pathology,
* Symptomatic orthostatic hypotension,
* Severe depressive syndrome untreated
* Subjects with a sufficient gap to explain the falls:

* cerebellar syndrome,
* a pyramidal syndrome with sequelae pyramidal deficit and cortical stroke
* peripheral pathology,
* rheumatic disease,
* orthopedic pathology,
* Mini Metam State Examination \<18,
* Parkinsonism induced by neuroleptics,
* Not cured cancer,
* Psychotropic drugs (benzodiazepines and antipsychotics) with significant sedative effect inducing excessive daytime sleepiness namely psychotropic half long life, and high dose over 2 psychotropic
* Severe heart failure
* Severe respiratory failure,
* Associated diseases and treatments interfering

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No